• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外组装和稳定登革热和寨卡病毒包膜蛋白同源二聚体。

In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers.

机构信息

Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, NC, USA.

出版信息

Sci Rep. 2017 Jul 3;7(1):4524. doi: 10.1038/s41598-017-04767-6.

DOI:10.1038/s41598-017-04767-6
PMID:28674411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5495877/
Abstract

Zika virus (ZIKV) and the 4 dengue virus (DENV) serotypes are mosquito-borne Flaviviruses that are associated with severe neuronal and hemorrhagic syndromes. The mature flavivirus infectious virion has 90 envelope (E) protein homo-dimers that pack tightly to form a smooth protein coat with icosahedral symmetry. Human antibodies that strongly neutralize ZIKV and DENVs recognize complex quaternary structure epitopes displayed on E-homo-dimers and higher order structures. The ZIKV and DENV E protein expressed as a soluble protein is mainly a monomer that does not display quaternary epitopes, which may explain the modest success with soluble recombinant E (sRecE) as a vaccine and diagnostic antigen. New strategies are needed to design recombinant immunogens that display these critical immune targets. Here we present two novel methods for building or stabilizing in vitro E-protein homo-dimers that display quaternary epitopes. In the first approach we immobilize sRecE to enable subsequent dimer generation. As an alternate method, we describe the use of human mAbs to stabilize homo-dimers in solution. The ability to produce recombinant E protein dimers displaying quaternary structure epitopes is an important advance with applications in flavivirus diagnostics and vaccine development.

摘要

Zika 病毒 (ZIKV) 和 4 种登革热病毒 (DENV) 血清型都是蚊媒传播的黄病毒,与严重的神经元和出血综合征有关。成熟的黄病毒感染性病毒粒子有 90 个包膜 (E) 蛋白同源二聚体,紧密包装形成具有二十面体对称性的光滑蛋白衣壳。强烈中和 ZIKV 和 DENVs 的人抗体识别 E-同源二聚体和更高阶结构上展示的复杂四级结构表位。作为可溶性蛋白表达的 ZIKV 和 DENV E 蛋白主要是单体,不显示四级表位,这可能解释了可溶性重组 E (sRecE) 作为疫苗和诊断抗原的效果并不理想。需要新的策略来设计展示这些关键免疫靶标的重组免疫原。在这里,我们提出了两种构建或稳定体外 E 蛋白同源二聚体以显示四级表位的新方法。在第一种方法中,我们将 sRecE 固定化以实现随后的二聚体生成。作为替代方法,我们描述了使用人单克隆抗体在溶液中稳定同源二聚体的方法。能够产生展示四级结构表位的重组 E 蛋白二聚体是在黄病毒诊断和疫苗开发中有应用的重要进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/504706be5eed/41598_2017_4767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/0d572c7a9064/41598_2017_4767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/3160b072c8ad/41598_2017_4767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/795e9313698a/41598_2017_4767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/d7aac7997215/41598_2017_4767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/15a3db14bb44/41598_2017_4767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/504706be5eed/41598_2017_4767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/0d572c7a9064/41598_2017_4767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/3160b072c8ad/41598_2017_4767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/795e9313698a/41598_2017_4767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/d7aac7997215/41598_2017_4767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/15a3db14bb44/41598_2017_4767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37b/5495877/504706be5eed/41598_2017_4767_Fig6_HTML.jpg

相似文献

1
In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers.在体外组装和稳定登革热和寨卡病毒包膜蛋白同源二聚体。
Sci Rep. 2017 Jul 3;7(1):4524. doi: 10.1038/s41598-017-04767-6.
2
Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins.生理温度降低登革热和 Zika 病毒重组包膜蛋白的二聚化。
J Biol Chem. 2018 Jun 8;293(23):8922-8933. doi: 10.1074/jbc.RA118.002658. Epub 2018 Apr 20.
3
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.鉴定与人结合的登革病毒粒子上复杂表位的中和抗体。
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.
4
Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.带有包膜蛋白共价二聚体的寨卡病毒样颗粒可保护小鼠免受致死性挑战。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01415-20.
5
A conserved set of mutations for stabilizing soluble envelope protein dimers from dengue and Zika viruses to advance the development of subunit vaccines.一组保守突变可稳定登革热和 Zika 病毒的可溶性包膜蛋白二聚体,从而推进亚单位疫苗的开发。
J Biol Chem. 2022 Jul;298(7):102079. doi: 10.1016/j.jbc.2022.102079. Epub 2022 May 26.
6
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.登革病毒样颗粒模拟了感染性登革病毒包膜的抗原特性。
Virol J. 2018 Apr 2;15(1):60. doi: 10.1186/s12985-018-0970-2.
7
Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.开发包膜蛋白抗原以血清学方法区分 Zika 病毒感染与登革热病毒感染。
J Clin Microbiol. 2018 Feb 22;56(3). doi: 10.1128/JCM.01504-17. Print 2018 Mar.
8
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.一种经包膜修饰的四价登革病毒样颗粒疫苗对黄病毒疫苗设计具有启示意义。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01181-17. Print 2017 Dec 1.
9
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.从登革热患者中分离出的登革病毒包膜二聚体表位单克隆抗体对寨卡病毒具有保护作用。
mBio. 2016 Jul 19;7(4):e01123-16. doi: 10.1128/mBio.01123-16.
10
Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.定义黄病毒包膜蛋白糖基化位点突变对广泛中和抗体敏感性的影响。
mBio. 2024 Feb 14;15(2):e0304823. doi: 10.1128/mbio.03048-23. Epub 2024 Jan 9.

引用本文的文献

1
Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens.开发一种可扩展的单一工艺来生产严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域(RBD)单体和二聚体疫苗抗原。
Front Bioeng Biotechnol. 2023 Nov 17;11:1287551. doi: 10.3389/fbioe.2023.1287551. eCollection 2023.
2
Evolution of a functionally intact but antigenically distinct DENV fusion loop.DENV 融合环的功能完整但抗原表位不同的进化。
Elife. 2023 Sep 19;12:RP87555. doi: 10.7554/eLife.87555.
3
Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop.

本文引用的文献

1
Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.温度依赖型折叠使登革热和 Zika 病毒的分泌型和病毒相关 E 蛋白在哺乳动物细胞中能够稳定二聚化。
Sci Rep. 2017 Apr 19;7(1):966. doi: 10.1038/s41598-017-01097-5.
2
An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model.一种针对寨卡病毒的 RNA 纳米颗粒疫苗在小鼠模型中引发抗体和 CD8+ T 细胞反应。
Sci Rep. 2017 Mar 21;7(1):252. doi: 10.1038/s41598-017-00193-w.
3
Neutralization mechanism of a highly potent antibody against Zika virus.
功能完整但抗原性不同的登革病毒融合环的演变
bioRxiv. 2023 Aug 4:2023.03.22.533803. doi: 10.1101/2023.03.22.533803.
4
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virus.靶向寨卡病毒复杂表位的人源抗体的结构与中和机制。
PLoS Pathog. 2023 Jan 10;19(1):e1010814. doi: 10.1371/journal.ppat.1010814. eCollection 2023 Jan.
5
Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge.寨卡病毒样颗粒疫苗融合环突变提高了产量,但不能保护 AG129 小鼠免受寨卡病毒挑战。
PLoS Negl Trop Dis. 2022 Jul 6;16(7):e0010588. doi: 10.1371/journal.pntd.0010588. eCollection 2022 Jul.
6
Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies.设计的、高表达的、热稳定的登革病毒2包膜蛋白二聚体可引发四级表位抗体。
Sci Adv. 2021 Oct 15;7(42):eabg4084. doi: 10.1126/sciadv.abg4084.
7
Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development.靶向寨卡和登革热的单克隆抗体全景:治疗解决方案和疫苗开发的关键见解。
Front Immunol. 2021 Feb 4;11:621043. doi: 10.3389/fimmu.2020.621043. eCollection 2020.
8
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.寨卡病毒包膜糖蛋白跨越结构域I和III的一个新型抗原位点是强效中和性人单克隆抗体的靶点。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.02423-20.
9
Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.登革病毒 E 亚基二聚化影响抗体功能和结构域聚焦。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00745-20.
10
Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?登革病毒的适应性免疫:合理疫苗设计的滑坡还是坚实基础?
Pathogens. 2020 Jun 15;9(6):470. doi: 10.3390/pathogens9060470.
抗寨卡病毒高效价抗体的中和机制。
Nat Commun. 2016 Nov 24;7:13679. doi: 10.1038/ncomms13679.
4
Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses.精确成型的展示登革病毒E蛋白的纳米颗粒诱导强烈的血清型特异性中和抗体反应。
PLoS Negl Trop Dis. 2016 Oct 20;10(10):e0005071. doi: 10.1371/journal.pntd.0005071. eCollection 2016 Oct.
5
Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation.寨卡病毒疫情的预防性疫苗:初步评估
EBioMedicine. 2016 Nov;13:315-320. doi: 10.1016/j.ebiom.2016.09.028. Epub 2016 Oct 3.
6
Vaccine Development for Zika Virus-Timelines and Strategies.寨卡病毒疫苗研发——时间表与策略
Semin Reprod Med. 2016 Sep;34(5):299-304. doi: 10.1055/s-0036-1592070. Epub 2016 Sep 8.
7
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.多种疫苗平台对恒河猴寨卡病毒攻击的保护效力
Science. 2016 Sep 9;353(6304):1129-32. doi: 10.1126/science.aah6157. Epub 2016 Aug 4.
8
Vaccines and immunization strategies for dengue prevention.登革热预防的疫苗和免疫策略。
Emerg Microbes Infect. 2016 Jul 20;5(7):e77. doi: 10.1038/emi.2016.74.
9
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.从登革热患者中分离出的登革病毒包膜二聚体表位单克隆抗体对寨卡病毒具有保护作用。
mBio. 2016 Jul 19;7(4):e01123-16. doi: 10.1128/mBio.01123-16.
10
Vaccine protection against Zika virus from Brazil.来自巴西的针对寨卡病毒的疫苗防护
Nature. 2016 Aug 25;536(7617):474-8. doi: 10.1038/nature18952. Epub 2016 Jun 28.